Changes in IgE- and antigen-dependent histamine-release in peripheral blood of Schistosoma mansoni-infected Ugandan fishermen after treatment with praziquantel

BMC Immunology

Volumn 5, Issue , 2004, Pages

  Satti, Mohamed Z ^a,g   Cahen, Pierre ^a   Skov, Per S ^b   Joseph, Sarah ^a   Jones, Frances M ^a   Fitzsimmons, Colin ^a   Hoffmann, Karl F ^a   Reimert, Claus ^f   Kariuki, H Curtis ^d   Kazibwe, Francis ^e   Mwatha, Joseph K ^c   Kimani, Gachuhi ^c   Vennervald, Birgitte J ^f   Ouma, John H ^d   Kabatereine, Narcis B ^e   Dunne, David W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Reference Laboratory   (Denmark)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d MINISTRY OF HEALTH   (Kenya)

^e MINISTRY OF HEALTH   (Uganda)

^f DANISH BILHARZIASIS LABORATORY   (Denmark)

^g KING KHALID UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; FC RECEPTOR; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; PARASITE ANTIGEN; PRAZIQUANTEL;

ADULT; ARTICLE; BASOPHIL; BLOOD SAMPLING; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS LINKING; DESENSITIZATION; DRUG HYPERSENSITIVITY; EOSINOPHIL; FISHERMAN; HISTAMINE BLOOD LEVEL; HISTAMINE RELEASE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; INFECTION RESISTANCE; MALE; MAST CELL; OCCUPATIONAL EXPOSURE; PERIPHERAL CIRCULATION; REINFECTION; SCHISTOSOMA; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; UGANDA;

ANIMALS; ANTHELMINTICS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIGENS, HELMINTH; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FISHERIES; HISTAMINE; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; MALE; PRAZIQUANTEL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SPECTROMETRY, FLUORESCENCE; TIME FACTORS; UGANDA;

EID: 2542471714     PISSN: 14712172     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2172-5-6     Document Type: Article

References (42)

1. Roberts M, Butterworth AE, Kimani G, Kamau T, Fulford AJ, Dunne DW, Ouma JH, Sturrock RF: Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection. Infect Immun 1993, 61:4984-4993.
2. Medhat A, Shehata M, Bucci K, Mohamed S, Dief AD, Badary S, Galal H, Nafeh M, King CL: Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment. J Infect Dis 1998, 178:512-519.
3. Hagan P, Blumenthal UJ, Chaudri M, Greenwood BM, Hayes RJ, Hodgson I, Kelly C, Knight M, Simpson AJ, Smithers SR, et al.: Resistance to reinfection with Schistosoma haematobium in Gambian children: analysis of their immune responses. Trans R Soc Trop Med Hyg 1987, 81:938-946.
4. Hagan P, Blumenthal UJ, Dunn D, Simpson AJ, Wilkins HA: Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991, 349:243-245.
5. Rihet P, Demeure CE, Bourgois A, Prata A, Dessein AJ: Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur J Immunol 1991, 21:2679-2686.
6. Zhang Z, Wu H, Chen S, Hu L, Xie Z, Qiu Y, Su C, Cao JP, Wu Y, Zhang S, Wu G: Association between IgE antibody against soluble egg antigen and resistance to reinfection with Schistosoma japonicum. Trans R Soc Trop Med Hyg 1997, 91:606-608.
7. Dunne DW, Butterworth AE, Fulford AJ, Kariuki HC, Langley JG, Ouma JH, Capron A, Pierce RJ, Sturrock RF: Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol 1992, 22:1483-1494.
8. Webster M, Fulford AJ, Braun G, Ouma JH, Kariuki HC, Havercroft JC, Gachuhi K, Sturrock RF, Butterworth AE, Dunne DW: Human immunoglobulin E responses to a recombinant 22.6-kilodalton antigen from Schistosoma mansoni adult worms are associated with low intensities of reinfection after treatment. Infect Immun 1996, 64:4042-4046.
9. Capron M, Capron A: Effector functions of eosinophils in schistosomiasis. Mem Inst Oswaldo Cruz 1992, 87 Suppl 4:167-170.
10. Clegg JA, Smithers SR, Terry RJ: Acquisition of human antigens by Schistosoma mansoni during cultivation in vitro. Nature 1971, 232:653-654.
11. Moser G, Wassom DL, Sher A: Studies of the antibody-dependent killing of schistosomula of Schistosoma mansoni employing haptenic target antigens. I. Evidence that the loss in susceptibility to immune damage undergone by developing schistosomula involves a change unrelated to the masking of parasite antigens by host molecules. J Exp Med 1980, 152:41-53.
12. Schramm G, Falcone FH, Gronow A, Haisch K, Mamat U, Doenhoff MJ, Oliveira G, Galle J, Dahinden CA, Haas H: Molecular characterization of an interleukin-4-inducing factor from Schistosoma mansoni eggs. J Biol Chem 2003, 278:18384-18392.
13. Rao KV, Chen L, Gnanasekar M, Ramaswamy K: Cloning and characterization of a calcium-binding, histamine-releasing protein from Schistosoma mansoni. J Biol Chem 2002, 277:31207-31213.
14. Araujo MI, Lopes AA, Medeiros M, Cruz AA, Sousa-Atta L, Sole D, Carvalho EM: Inverse association between skin response to aeroallergens and Schistosoma mansoni infection. Int Arch Allergy Immunol 2000, 123:145-148.
15. van den Biggelaar AH, van Ree R, Rodrigues LC, Lell B, Deelder AM, Kremsner PG, Yazdanbakhsh M: Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 2000, 356:1723-1727.
16. Leopold G, Ungethum W, Groll E, Diekmann HW, Nowak H, Wegner DH: Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes. An example of a complex study covering both tolerance and pharmacokinetics. Eur J Clin Pharmacol 1978, 14:281-291.
17. Fallon PG, Fookes RE, Wharton GA: Temporal differences in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for drug-antibody synergy. Parasitology 1996, 112 (Pt 1):47-58.
18. Berhe N, Gundersen SG, Abebe F, Birrie H, Medhin G, Gemetchu T: Praziquantel side effects and efficacy related to Schistosoma mansoni egg loads and morbidity in primary school children in north-east Ethiopia. Acta Trop 1999, 72:53-63.
19. Ottesen EA, Poindexter RW, Hussain R: Detection, quantitation, and specificity of antiparasite IgE antibodies in human schistosomiasis mansoni. Am J Trop Med Hyg 1981, 30:1228-1237.
20. Derouin F, Rouveix B, Sarfati C: IgE response and histamine release in chronic human schistosomiasis. Biomed Pharmacother 1985, 39:32-35.
21. Stevens WJ, Feldmeir H, Bridts CH, Daffalla AA: IgG and IgE circulating immune complexes, total serum IgE and parasite related IgE in patients with mono- or mixed infection with Schistosoma mansoni and/or S. haematobium. Influence of therapy. Clin Exp Immunol 1983, 52:144-152.
22. Wittig HJ, Belloit J, De Fillippi I, Royal G: Age-related serum immunoglobulin E levels in healthy subjects and in patients with allergic disease. J Allergy Clin Immunol 1980, 66:305-313.
23. Moverare R, Vesterinen E, Metso T, Sorva R, Elfman L, Haahtela T: Pollen-specific rush immunotherapy: clinical efficacy and effects on antibody concentrations. Ann Allergy Asthma Immunol 2001, 86:337-342.
24. Petersson BA, Stalenheim G: Induction of histamine release and densensitization in human leukocytes. Scand J Immunol 1975, 4:103-112.
25. Mendoza GR, Minagawa K: Subthreshold and suboptimal desensitization of human basophils. II. Nonspecificity and irreversibility of desensitization. Int Arch Allergy Appl Immunol 1982, 69:282-284.
26. Dembo M, Goldstein B: A model of cell activation and desensitization by surface immunoglobin: the case of histamine release from human basophils. Cell 1980, 22:59-67.
27. Tedeschi A, Lorini M, Arquati M, Miadonna A: Regulation of histamine release from human basophil leucocytes: role of H1, H2 and H3 receptors. Allergy 1991, 46:626-631.
28. Pedersen M, Kristensen KS, Clementsen P, Olsen OT, Skov PS, Permin H, Norn S: Increased numbers of circulating basophils with decreased releasability after administration of rhG-CSF to allergic patients. Agents Actions 1994, 41 Spec No:C24-5.
29. de Jonge N, De Caluwe P, Hilberath GW, Krijger FW, Polderman AM, Deelder AM: Circulating anodic antigen levels in serum before and after chemotherapy with praziquantel in schistosomiasis mansoni. Trans R Soc Trop Med Hyg 1989, 83:368-372.
30. Pierkes M, Bellinghausen I, Hultsch T, Metz G, Knop J, Saloga J: Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-gamma production of T cells. J Allergy Clin Immunol 1999, 103:326-332.
31. Haisch K, Schramm G, Falcone FH, Alexander C, Schlaak M, Haas H: A glycoprotein from Schistosoma mansoni eggs binds nonantigen-specific immunoglobulin E and releases interleukin-4 from human basophils. Parasite Immunol 2001, 23:427-434.
32. Mita H, Yasueda H, Akiyama K: Affinity of IgE antibody to antigen influences allergen-induced histamine release. Clin Exp Allergy 2000, 30:1583-1589.
33. Marchand F, Mecheri S, Guilloux L, Iannascoli B, Weyer A, Blank U: Human serum IgE-mediated mast cell degranulation shows poor correlation to allergen-specific IgE content. Allergy 2003, 58:1037-1043.
34. Eich-Wanger C, Muller UR: Bee sting allergy in beekeepers. Clin Exp Allergy 1998, 28:1292-1298.
35. Gerken SE, Vaz NM, Mota-Santos TA: Local anaphylactic reactions to the penetration of cercariae of Schistosoma mansoni. Braz J Med Biol Res 1990, 23:275-281.
36. Katz N, Chaves A, Pellegrino J: A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972, 14:397-400.
37. Satti MZ, Ebbesen F, Vennervald B, Lind P, Ghalib H, Sulaiman S, Daffalla A, Skov PS: Use of a new glass microfibre histamine release method to study the modulation of the host response in human schistosomiasis mansoni. Individuals with different degrees of exposure to the disease show differing antibody biological function. Trop Med Int Health 1996, 1:655-666.
38. Smithers SR, Terry RJ: The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology 1965, 55:695-700.
39. Webster M, Libranda-Ramirez BD, Aligui GD, Olveda RM, Ouma JH, Kariuki HC, Kimani G, Olds GR, Fulford AJ, Butterworth AE, Dunne DW: The influence of sex and age on antibody isotype responses to Schistosoma mansoni and Schistosoma japonicum in human populations in Kenya and the Philippines. Parasitology 1997, 114 (Pt 4):383-393.
40. Dunne DW, Lucas S, Bickle Q, Pearson S, Madgwick L, Bain J, Doenhoff MJ: Identification and partial purification of an antigen (omega 1) from Schistosoma mansoni eggs which is putatively hepatotoxic in T-cell deprived mice. Trans R Soc Trop Med Hyg 1981, 75:54-71.
41. Deelder AM, De Jonge N, Boerman OC, Fillie YE, Hilberath GW, Rotmans JP, Gerritse MJ, Schut DW: Sensitive determination of circulating anodic antigen in Schistosoma mansoni infected individuals by an enzyme-linked immunosorbent assay using monoclonal antibodies. Am J Trop Med Hyg 1989, 40:268-272.
42. De Jonge N, Fillie YE, Deelder AM: A simple and rapid treatment (trichloroacetic acid precipitation) of serum samples to prevent non-specific reactions in the immunoassay of a proteoglycan. J Immunol Methods 1987, 99:195-197.